Pathologists at the Stanford University School of Medicine are trying out a new test from a Sunnyvale company that could give cancer patients a better chance of getting the most effective treatment.

A pioneering AI-enabled multi-cancer blood test, developed with the NHS in England, will be among the headline innovations ...

Life Technologies acquired Pinpoint Genomics and its early-stage non-small-cell lung cancer test. The test is designed to identify early-stage patients at high risk for progression to late-stage ...

Colon cancer is one of the top three deadliest forms of cancer - in part because it's often diagnosed so late. Now a groundbreaking study could pinpoint the disease easier, and earlier. The ...

PinPoint's test has been developed with the support of NHS England (image credit: Pixabay) A business behind AI-driven cancer diagnostic software which is designed to "enhance diagnostic accuracy and ...